Aims & Scope
The aim of Canadian Dermatology Today is to provide clinicians with perspective and insight on the management of dermatological disease and to provide a forum for clinicians to share their real-world experience in the treatment and management of their patients.
Peer Review Policy
Canadian Dermatology Today is a fully peer-reviewed journal.
All articles published in Canadian Dermatology Today are subject to review by the Editorial Board, which is comprised of established clinicians with extensive publication records in the field of dermatology. The Editorial Board will evaluate submitted manuscripts against Canadian Dermatology Today’s aims and the publication criteria outlined below.
Editors shall disclose any relationships or activities that may bias their review of the manuscript and shall recuse themselves from reviews or editorial decisions that pose a potential conflict of interest.
Journal Editorial Board
MSc, MD, FRCPC
Medical Director, SKiN Health Investigator, Probity Medical Research Assistant Professor, Queen’s University
Clinical Assistant Professor, Department of Dermatology and Skin Science, University of British Columbia Director, Dr. Chih-ho Hong Medical Inc. and SkinFIT MD
Medical Director, PERC Dermatology, Women’s College Hospital Consultant Dermatologist, Sunnybrook Health Sciences Centre Assistant Professor, Department of Medicine, University of Toronto Investigator, K. Papp Clinical Research, Probity Medical Research, Waterloo, ON
MD, PhD, FRCPC
K Papp Clinical Research Probity Medical Research
The main article types we accept are as follows:
Case Reports (≤1000 words): Case reports should outline a clinical situation that illustrates unique or atypical features or provide a lesson to be learned that is relevant to dermatological care. Case reports should include a brief introduction, a description of the case and discussion, including relevance, implications and recommendations. Case reports do not require an abstract. Articles in this section should not exceed 1000 words in length and may contain up to 2 figures and/or tables. The reference list should not exceed 20 references. Written informed consent from the patient(s) or their guardians(s) should be obtained before submission.
Practical Dermatology (≤2000 words): Articles under this section should be structured like review articles, be well-referenced and focus on any aspect of the care of people with dermatological disease. Practical Dermatology articles must also include an abstract, although it need not be structured (maximum 250 words). Practical dermatology articles could include review of new resources relevant to the care and education of people with dermatological disease. Articles in this section should not exceed 2000 words in length and may contain up to 2 figures and/or tables. The reference list should not exceed 25.
Perspectives in Practice (≤2000 words): This section provides a format for authors to discuss new programs or services, ideas, insights or practical approaches to dermatological care and education or professional development. Papers in this section should be well-referenced. Articles in this section should not exceed 2000 words in length and may contain up to 2 figures and/or tables. The reference list should not exceed 25 references.
Innovations in Dermatological Care (≤700 words): Papers in this section review new resources relevant to the care and education of people with dermatological disease. They may comment on range and depth of contents, readability level, design, approach, price and graphic elements. Articles in this section should not exceed 700 words in length and may contain 1 figure or table. The reference list should not exceed 10 references.
Dermatological Dilemmas (≤850 words): This feature is intended to highlight interesting and challenging cases in dermatology. This may include: diagnostic considerations, a picture to illustrate a clinical feature, management challenges and complications. The case should illustrate an approach to the problem and provide a succinct summary of take-home points. The case presentation should be 250 words (maximum) and clearly demonstrate the clinical dermatological challenge. Alternatively, a picture or illustration can be submitted instead of the case presentation provided it demonstrates the challenge. The case presentation should be followed by a discussion that is 600 words (maximum) outlining the approach to the clinical dermatological challenge. One figure or table may be included. Reference list should not exceed 10 references. Written informed consent from the patient(s) or their guardians(s) should be obtained before submission.
Manuscripts for Canadian Dermatology Today should be submitted online at firstname.lastname@example.org. The submitting author, who is generally the corresponding author, is responsible for the manuscript during the submission and peer-review process and must ensure that queries, revisions and approvals can be provided in a 72-hour time period during the review of their manuscript.
Accepted File Formats
Authors must use Microsoft Word to prepare their manuscript. Manuscripts prepared in Microsoft Word must be converted into a single file before submission. When preparing manuscripts in Microsoft Word, please insert graphics (schemes, figures, etc.) in the main text after the paragraph of its first citation.
We do not have strict formatting requirements, but all manuscripts must contain the required sections as appropriate for the type of manuscript being submitted, such as the following in the case of an article:
Author Information, Abstract, Keywords, Introduction, Materials & Methods, Results, Conclusions, Figures and Tables with Captions, Funding Information, Author Contributions, Conflict of Interest and other Ethics Statements.
References are preferred in MLA format but may be submitted in any style, provided that you use the consistent formatting throughout. It is essential to include author(s) name(s), journal or book title, article or chapter title (where required), year of publication, volume and issue (where appropriate) and pagination. DOI numbers (Digital Object Identifier) are not mandatory but highly encouraged. The bibliography software package EndNote, Zotero, Mendeley, Reference Manager are recommended.
Author Biography and Headshot
Authors are required to provide a biography (maximum 150 words) with their submission and publish it. This should be a single paragraph and should contain the following points:
- Authors’ full names followed by current positions;
- Education background including institution information and year of graduation (type and level of degree received);
- Work experience;
- Current and previous research interests;
- Memberships of professional societies and awards received
- A hi-resolution headshot must accompany the author’s manuscript. Typically, these can be taken with any current smartphone and should include an image of the author’s full face from the shoulders up.
All advertisements and commercially sponsored publications are independent from editorial decisions. Canadian Dermatology Today does not endorse any product or service marked as an advertisement or promoted by a sponsor in Canadian Dermatology Today publications. Editorial content is not compromised by commercial or financial interests, or by any specific arrangements with advertising clients or sponsors.
All advertisements for drug-specific campaigns must comply with the relevant Canadian legislation that regulates advertising. All advertisements for drug specific campaigns should encourage correct and rational, may not be deceptive or misleading, and must be verifiable. Advertisements should clearly identify the advertiser and the product or service being offered.
Canadian Dermatology Today reserves the right to reject any manuscript on the basis of unethical conduct in either human or animal studies.
For research involving human experiments, the article must include a statement that ethical approval was obtained (or a statement that ethical approval was not required and why) and a statement that the participants gave informed consent before taking part (or a statement that consent was not required and why).
Where illustrations include recognizable individuals, living or deceased, authors must ensure that consent for publication has been given and patient anonymity should be preserved.
Individual participants in studies have the right to decide what happens to identifiable personal data gathered, to what they have said during a study or an interview, as well as to any photograph that was taken. This is especially true concerning images of vulnerable people (e.g. minors, patients, refugees, etc) or the use of images in sensitive contexts. In many instances authors will need to secure written consent before including images.
Identifying details of the participants that were studied should not be published in written descriptions unless the information is essential for scholarly purposes and the participant gave written informed consent for publication.
In cases were complete anonymity is difficult to achieve, informed consent for publication should be obtained if there is any doubt.
Corrections & Retractions
Canadian Dermatology Today will issue corrections, retraction statements and other post-publication updates including Editorial Expressions of Concern on published content as appropriate. Substantial errors to supplementary information are corrected in the same manner as amendments to the main article.
When making corrections to articles, in the majority of cases the original article is corrected and is linked to and from the published amendment notice, which details the original error. For the sake of transparency, when changes made to the original article affect data in figures, tables or text (for example, when data points/error bars change or curves require redrawing) the amendment notice will reproduce the original data. When it is not possible to correct the original article in both HTML and PDF versions (for example, articles published many years before the error is raised) the article will remain unchanged but will links to and from the published amendment notice.